Skip to content

Clinical trial of spirit-regulation with acupuncture in improving chronic musculoskeletal pain

Clinical trial of spirit-regulation with acupuncture in improving chronic musculoskeletal pain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000338
Enrollment
Unknown
Registered
2024-08-31
Start date
2024-09-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic musculoskeletal pain

Interventions

regular electroacupuncture group:Combination of Local and Meridian Acupoint Selection
regular electroacupuncture combined with spirit-regulation electroacupuncture group :regular electroacupuncture combined with spirit-regulation electroacupuncture
drug group:Oral administration of celecoxib capsules

Sponsors

China Resources & Wugang General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Consistent with the diagnostic criteria for chronic musculoskeletal pain proposed in the "Expert Consensus on Drug Therapy for Chronic Musculoskeletal Pain (2018)", that is, pain that has occurred in muscles, skeletons, joints, tendons, or soft tissues for =3 months, such as patients with rheumatoid arthritis, low back pain, neck and shoulder pain, knee arthritis, etc.; 2. VAS score =4; 3. Age =18 years; 4. Clear consciousness, accurate language expression, and the ability to communicate normally.

Exclusion criteria

Exclusion criteria: 1) Patients with other severe major diseases such as cardiopulmonary, hepatic, or renal disorders; 2) Individuals with severe mental illnesses and cognitive dysfunction; 3) Patients who decline to participate; 4) Patients with chronic musculoskeletal pain caused by infectious diseases; 5) Women who are pregnant or breastfeeding; 6) Individuals intolerant to nonsteroidal anti-inflammatory drugs (NSAIDs).

Design outcomes

Primary

MeasureTime frame
VAS score of pain;

Secondary

MeasureTime frame
Hamilton Depression Scale;Hamilton Anxiety Scale;Serum levels of neurotransmitters;

Countries

China

Contacts

Public ContactYanan Yang

China Resources & Wugang General Hospital

yangyanan10@crmedical.hk15972224592

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026